235 related articles for article (PubMed ID: 17556903)
1. Metabolic and inflammatory faecal markers in collagenous colitis.
Wildt S; Nordgaard-Lassen I; Bendtsen F; Rumessen JJ
Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):567-74. PubMed ID: 17556903
[TBL] [Abstract][Full Text] [Related]
2. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
Joshi S; Lewis SJ; Creanor S; Ayling RM
Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
[TBL] [Abstract][Full Text] [Related]
3. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of four fecal assays in the diagnosis of colitis.
Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
[TBL] [Abstract][Full Text] [Related]
5. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis.
Lettesjö H; Hansson T; Peterson C; Ung KA; Ringström G; Abrahamsson H; Simrén M
Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers.
Larsen A; Hovdenak N; Karlsdottir A; Wentzel-Larsen T; Dahl O; Fagerhol MK
Scand J Gastroenterol; 2004 Nov; 39(11):1113-8. PubMed ID: 15545170
[TBL] [Abstract][Full Text] [Related]
8. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
10. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.
Sipponen T; Kärkkäinen P; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
Aliment Pharmacol Ther; 2008 Nov; 28(10):1221-9. PubMed ID: 18752630
[TBL] [Abstract][Full Text] [Related]
11. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
Sipponen T; Björkesten CG; Färkkilä M; Nuutinen H; Savilahti E; Kolho KL
Scand J Gastroenterol; 2010 Mar; 45(3):325-31. PubMed ID: 20034360
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
Schröder O; Naumann M; Shastri Y; Povse N; Stein J
Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
[TBL] [Abstract][Full Text] [Related]
15. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
[TBL] [Abstract][Full Text] [Related]
16. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.
Lamb CA; Mohiuddin MK; Gicquel J; Neely D; Bergin FG; Hanson JM; Mansfield JC
Br J Surg; 2009 Jun; 96(6):663-74. PubMed ID: 19384912
[TBL] [Abstract][Full Text] [Related]
17. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.
Casellas F; Borruel N; Torrejón A; Varela E; Antolin M; Guarner F; Malagelada JR
Aliment Pharmacol Ther; 2007 May; 25(9):1061-7. PubMed ID: 17439507
[TBL] [Abstract][Full Text] [Related]
18. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.
Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS
Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771
[TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin: a new marker for Crohn's disease?
Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
[TBL] [Abstract][Full Text] [Related]
20. [Fecal excretion of short-chain fatty acids as a marker of the severity of ulcerative colitis].
Kosacheva TA; Sil'vestrova SIu; Drozdov VN
Ter Arkh; 2010; 82(2):48-51. PubMed ID: 20387676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
